See more : OncoSil Medical Limited (OSL.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Medhelp Care Aktiebolag (publ) (MEDHLP.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medhelp Care Aktiebolag (publ), a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- BankInvest – Virksomhedsobligationer IG KL (BAIVOIGA.CO) Income Statement Analysis – Financial Results
- Laox CO., LTD. (8202.T) Income Statement Analysis – Financial Results
- AJ Lucas Group Limited (AJL.AX) Income Statement Analysis – Financial Results
- Upexi, Inc. (GRVI) Income Statement Analysis – Financial Results
- Aeroports de Paris SA (AEOXF) Income Statement Analysis – Financial Results
Medhelp Care Aktiebolag (publ) (MEDHLP.ST)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.medhelp.se
About Medhelp Care Aktiebolag (publ)
Medhelp Care Aktiebolag (Publ), a software-as-a-service company, operates a cloud platform for occupational health and support services in Sweden. It offers absence management, healthcare counseling, rehab support, and staffing planning services, as well as sick leave statistics. The company was founded in 1999 and is based in Stockholm, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 84.08M | 80.61M | 78.03M | 67.06M | 62.45M | 58.65M |
| Cost of Revenue | -6.30M | -6.56M | -3.39M | 25.85M | 11.13M | 9.49M |
| Gross Profit | 90.39M | 87.18M | 81.43M | 41.20M | 51.32M | 49.16M |
| Gross Profit Ratio | 107.50% | 108.14% | 104.35% | 61.44% | 82.18% | 83.81% |
| Research & Development | 0.00 | 8.43M | 14.68M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 42.82M | 33.63M | 45.03M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 41.75M | 42.82M | 33.63M | 45.03M | 43.44M |
| Other Expenses | 100.87M | 95.82M | 47.01M | 26.89M | 11.13M | 0.00 |
| Operating Expenses | 100.87M | 95.82M | 89.84M | 60.52M | 56.17M | 49.04M |
| Cost & Expenses | 94.57M | 89.26M | 86.44M | 60.52M | 56.17M | 58.53M |
| Interest Income | 110.00K | 617.00K | 8.00K | 9.00K | 9.00K | 68.00K |
| Interest Expense | 1.16M | 663.00K | 618.00K | 373.00K | 285.00K | 0.00 |
| Depreciation & Amortization | 11.54M | 9.33M | 15.58M | 12.23M | 6.00K | 6.00K |
| EBITDA | -3.88M | 1.98M | 8.47M | 14.95M | 6.29M | 5.72M |
| EBITDA Ratio | -4.62% | 2.46% | 10.86% | 23.22% | 9.83% | 9.75% |
| Operating Income | -10.48M | -7.35M | -7.80M | 4.12M | 6.28M | 5.71M |
| Operating Income Ratio | -12.47% | -9.12% | -9.99% | 6.14% | 10.06% | 9.74% |
| Total Other Income/Expenses | -1.05M | -46.00K | -6.00K | -2.97M | -433.00K | -5.66M |
| Income Before Tax | -11.53M | -8.69M | -8.42M | 3.75M | 5.85M | 50.00K |
| Income Before Tax Ratio | -13.71% | -10.78% | -10.79% | 5.58% | 9.36% | 0.09% |
| Income Tax Expense | -520.00K | -821.00K | -644.00K | 811.00K | 1.26M | 18.00K |
| Net Income | -11.01M | -7.87M | -7.77M | 2.93M | 4.58M | 32.00K |
| Net Income Ratio | -13.09% | -9.76% | -9.96% | 4.38% | 7.34% | 0.05% |
| EPS | -0.36 | -0.26 | -0.26 | 0.09 | 0.15 | 0.00 |
| EPS Diluted | -0.36 | -0.26 | -0.26 | 0.09 | 0.15 | 0.00 |
| Weighted Avg Shares Out | 30.43M | 30.43M | 30.43M | 32.05M | 30.43M | 30.43M |
| Weighted Avg Shares Out (Dil) | 30.43M | 30.43M | 30.43M | 32.05M | 30.43M | 30.43M |
Source: https://incomestatements.info
Category: Stock Reports